Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syria Laperche

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Infection Control and Hospital Epidemiology|June 27, 2002
Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine?Elisabeth Delarocque-Astagneau, Nadège Baffoy, Valérie Thiers, et al.
Blood|September 2, 2020
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donationPierre Cappy, Daniel Candotti, Virginie Sauvage, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Improving platelet transfusion safety: biomedical and technical considerationsOlivier Garraud, Fabrice Cognasse, Jean-Daniel Tissot, et al.
Viruses|November 24, 2022
Insights on 21 Years of HBV Surveillance in Blood Donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Transfusion|August 5, 2008
A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident casesSyria Laperche, Michèle Maniez, Valérie Barlet, et al.
Transfusion|January 28, 2022
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in FranceSophie Le Cam, Pierre Gallian, Céline Ricard, et al.
Blood Transfusion = Trasfusione Del Sangue|June 1, 2021
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Transfusion|February 7, 2020
The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in FranceJosiane Pillonel, Camille Pelat, Pierre Tiberghien, et al.
Vox Sanguinis|May 30, 2020
The use of the Geenius<sup>TM</sup> HIV-1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, AfricaClaude T Tagny, Marie Bissim, Rolande Djeumen, et al.
Transfusion|October 1, 2010
Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative studyJean-Jacques Lefrère, Honorine Dahourouh, Alexis E Dokekias, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Infection Control and Hospital Epidemiology|June 27, 2002
Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine?Elisabeth Delarocque-Astagneau, Nadège Baffoy, Valérie Thiers, et al.
Blood|September 2, 2020
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donationPierre Cappy, Daniel Candotti, Virginie Sauvage, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Improving platelet transfusion safety: biomedical and technical considerationsOlivier Garraud, Fabrice Cognasse, Jean-Daniel Tissot, et al.
Viruses|November 24, 2022
Insights on 21 Years of HBV Surveillance in Blood Donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Transfusion|August 5, 2008
A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident casesSyria Laperche, Michèle Maniez, Valérie Barlet, et al.
Transfusion|January 28, 2022
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in FranceSophie Le Cam, Pierre Gallian, Céline Ricard, et al.
Blood Transfusion = Trasfusione Del Sangue|June 1, 2021
Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in FrancePierre Cappy, Laure Boizeau, Daniel Candotti, et al.
Transfusion|February 7, 2020
The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in FranceJosiane Pillonel, Camille Pelat, Pierre Tiberghien, et al.
Vox Sanguinis|May 30, 2020
The use of the Geenius<sup>TM</sup> HIV-1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, AfricaClaude T Tagny, Marie Bissim, Rolande Djeumen, et al.
Transfusion|October 1, 2010
Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative studyJean-Jacques Lefrère, Honorine Dahourouh, Alexis E Dokekias, et al.
Pageof 15